Shoulder Innovations, Inc. (NYSE: SI) is a Healthcare company (Medical - Specialties) with a market capitalization of $430M. The Maz Rating grades it against the other companies in its sector.
Shoulder Innovations, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $20.56, Shoulder Innovations, Inc. trades at 6.7x sales and 3.6x book value. Over the last twelve months it generated about $64M of revenue and a net loss of $34M. It runs a gross margin of 77.8%, an operating margin of -54.4% and a net margin of -51.7%. It shows return on equity of -25.8%, return on invested capital of -26.3% and a free cash flow yield of -9.9%. On the balance sheet: a debt-to-equity ratio of 0.13 and a current ratio of 10.68. Over the past 52 weeks the share price ranged from $12.00 to $24.60, with a beta of -1.77.
Shoulder Innovations, Inc. does not currently pay a dividend.
4 Wall Street analyst ratings cover the stock: 4 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.